This is a non-core endpoint: only basic statistics are computed.
Pseudosarcomatous fibromatosis
M13_PSEUDOSARCFIBROMATOSIS
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
20
Check minimum number of events None
20
Include endpoints None
20
Remove individuals based on genotype QC
19
Control definitions
Extra metadata
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to Pseudosarcomatous fibromatosis based on the number of shared cases.
Broader endpoints:
- Fibroblastic disorders
- Soft tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Paracetamol of NSAID medication
- Any operation in hilmo
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 19 | 11 | 8 |
Unadjusted prevalence (%) | 0.00 | 0.00 | 0.00 |
Mean age at first event (years) | 47.69 | 42.55 | 54.75 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: M13_PSEUDOSARCFIBROMATOSIS – Pseudosarcomatous fibromatosis
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Pseudosarcomatous fibromatosis
↥Endpoint not on priority list, no data to show.